These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Ineffectiveness of vasopressin in the treatment of memory impairment in chronic schizophrenia. Stein D; Bannet J; Averbuch I; Landa L; Chazan S; Belmaker RH Psychopharmacology (Berl); 1984; 84(4):566-8. PubMed ID: 6441958 [TBL] [Abstract][Full Text] [Related]
8. Medicine's next level. Carmichael M Newsweek; 2004 Dec; 144(23):44-6, 49-50. PubMed ID: 15605719 [No Abstract] [Full Text] [Related]
9. Vasopressin and memory in Korsakoff syndrome. LeBoeuf A; Lodge J; Eames PG Lancet; 1978 Dec 23-30; 2(8104-5):1370. PubMed ID: 82860 [No Abstract] [Full Text] [Related]
10. [Case of memory disorder treated with vasopressin]. Calandra C; Drago F; Filetti S Minerva Psichiatr; 1980; 21(1):63-6. PubMed ID: 7464485 [No Abstract] [Full Text] [Related]
11. Prospects of memory-modifying drugs that target the CREB pathway. Jackson T; Ramaswami M Curr Opin Drug Discov Devel; 2003 Sep; 6(5):712-9. PubMed ID: 14579521 [TBL] [Abstract][Full Text] [Related]
12. Clinical trials in memory disorders: objectives and methodology. Alperovitch A Arch Gerontol Geriatr Suppl; 1989; 1():207-14. PubMed ID: 2757734 [No Abstract] [Full Text] [Related]
13. [A clinical study of recovery of memories in 46 cases of cerebrovascular diseases]. Xu WX; Guo YP Zhonghua Nei Ke Za Zhi; 1991 Dec; 30(12):752-4, 789. PubMed ID: 1815879 [TBL] [Abstract][Full Text] [Related]
14. Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function. Leckman J; Ananth JV; Ban TA; Lehmann HE J Clin Pharmacol New Drugs; 1971; 11(4):301-3. PubMed ID: 4932747 [No Abstract] [Full Text] [Related]
15. [Neuropsychology of memory]. Hamanaka T No To Shinkei; 1985 Aug; 37(8):727-52. PubMed ID: 3935146 [No Abstract] [Full Text] [Related]
16. [Experience with the use of posterior pituitary hormones in memory disorders of different etiology]. Akimov GA; Medvedev VI; Bakharev VD; Zagriadskiĭ PV; Stepovik NV Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(12):1787-90. PubMed ID: 6164188 [TBL] [Abstract][Full Text] [Related]
17. How to evaluate a drug efficacy at the behavioural level? Aquino JP; Poitrenaud J Arch Gerontol Geriatr Suppl; 1989; 1():249-53. PubMed ID: 2667547 [No Abstract] [Full Text] [Related]
18. [Vasopressin and its new therapeutic possibilities]. Pluta RM Neurol Neurochir Pol; 1984; 18(3):269-73. PubMed ID: 6390236 [No Abstract] [Full Text] [Related]
19. Huperzine A ameliorates the impaired memory of aged rat in the Morris water maze performance. Ye JW; Shang YZ; Wang ZM; Tang XC Acta Pharmacol Sin; 2000 Jan; 21(1):65-9. PubMed ID: 11263250 [TBL] [Abstract][Full Text] [Related]
20. The AMPA modulator S 18986 improves declarative and working memory performances in aged mice. Marighetto A; Valerio S; Jaffard R; Mormede C; Muñoz C; Bernard K; Morain P Behav Pharmacol; 2008 May; 19(3):235-44. PubMed ID: 18469541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]